Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Gut microbiota Modulated by Probiotics and Garcinia cambogia Extract Correlate with Weight Gain and Adipocyte Sizes in High Fat-Fed Mice


Results of recent studies on gut microbiota have suggested that obesogenic bacteria exacerbate obesity and metabolic dysfunction in the host when fed a high fat diet (HFD). In order to explore obesity-associated bacterial candidates and their response to diet, the composition of faecal bacterial communities was investigated by analyzing 16S rRNA gene sequences in mice. Dietary intervention with probiotics and Garcinia cambogia extract attenuated weight gain and adipocyte size in HFD-fed mice. To identify obesity-causative microbiota, two statistical analyses were performed. Forty-eight bacterial species were found to overlap between the two analyses, indicating the commonly identified species as diet-driven and obesity-associated, which would make them strong candidates for host-microbiome interaction on obesity. Finally, correlation based network analysis between diet, microbe, and host revealed that Clostridium aminophilum, a hyper-ammonia-producing bacterium, was highly correlated with obesity phenotypes and other associated bacteria, and shown to be suppressed by the combination of probiotics and Garcinia cambogia extract. Results of the present study suggest that probiotics and Garcinia cambogia extract alleviate weight gain and adiposity, in part via differentially modulating the composition of gut microbiota in HFD fed mice.


Obesity is a rapidly growing global health epidemic which confers great risk for the development of serious health issues such as diabetes, cardiovascular disease, and cancer1. Host-microbe studies unveiled the role of gut microbiota modifying immune responses2, inflammation and insulin resistance in the development of diet-induced obesity in animals3. Recent studies which involved transplanting faecal microbiota from obese humans to germ-free mice revealed that the gut microbiota itself may induce obesity2,3. Recent findings in the proportion of two major bacterial phyla (Firmicutes and Bacteriodetes) and their ratio between obese and lean samples (in humans and animals)4,5 have promoted the investigation of microbial candidates associated with obesity. Although growing evidence suggests positively or negatively obesity-associated microbes at various taxa6, only a few species have been well studied and understood6,7,8,9.

During the past decade, many researchers have focused on studying Firmicutes and its characteristic of increasing the capacity of energy harvest from indigestible sources in diet5,10,11, mainly due to carbohydrate metabolism processes. However, recent studies have observed that a western-style diet increases gut microbial amino acid metabolism in humans and animals8,12. High-fat feeding particularly increases microbial proteins of amino acid metabolism, which leads to the exceeding changes of gut microbial community composition in mice12. Short-term consumption of an animal-based diet compared to a plant-based diet significantly increases the faecal concentration of branched short chain fatty acids such as isovalerate and isobutyrate from amino acid fermentation in humans, indicating a quick shift between carbohydrate and amino acid fermentation in gut microbiota8.

Previous studies have indicated that dietary intervention such as probiotics and polyphenol-rich fruit extracts changes the composition of gut microbiota, and reduces visceral adiposity and obesity in animals13,14,15,16. Probiotics change the proportions of metabolic syndrome-related phylotypes in high fat fed mice, which differentially influences gut microbiota14. Garcinia cambogia extract containing hydroxycitric acid, known as an inhibitor of ATP-citrate-lyase in fatty acid biosynthesis, is polyphenol-rich and shows antibacterial and antioxidant properties.

In this study, we aimed to investigate which gut microbes respond to dietary intervention such as high fat, probiotics, and Garcinia cambogia extract, as well as whether they are associated with obesity phenotypes in diet-induced obese mice. After 9 weeks of dietary intervention, three types of metagenome analysis on faecal microbial communities were performed to detect obesity-causative microbes responding to diet: 1) identification of differentially abundant microbiota (DAM); 2) identification of obesity trait-associated microbiota (TAM); and 3) network analysis in order to consider comprehensive information underlying gut microbiome features of diet-microbe interaction, host-microbe interaction, microbe-microbe interaction, and finally all combined interactions.


Adipocyte sizes sensitively respond to a high-fat diet

To evaluate obesity traits responding to diet, male C57BL/6J mice were fed a low-fat diet (LFD), HFD, HFD with probiotics (HFD + P) and HFD with a combination of probiotics and Garcinia cambogia extract (HFD + P + G) for 9 weeks, respectively (diet information provided in Table S1, n = 7 for each treatment). Body weight was significantly lower in LFD mice after 4 weeks and in HFD + P + G mice after 6 weeks compared to HFD mice at 5% significance level (Fig. 1a and Table S2). Body weight gain was 58%, 13%, 31% lower in LFD mice, HFD + P mice, and HFD + P + G mice, respectively, compared to HFD mice (Table S3). All fat pad mass proportions to body weight in LFD were lower compared to HFD mice (Table S3). The mean sizes of adipocytes from perirenal, epididymal, and mesenteric adipose tissues (PAT, EAT, and MAT, respectively) were lower in HFD + P mice than those from HFD mice (Fig. 1b), except for subcutaneous (SAT) adipocyte. The density plots of adipocyte sizes showed a similar pattern, with mean values arranged in order from LFD to HFD groups (Fig. 1c). Adipocyte sizes of each mouse showed individual variability responding to diet which we determine, in part, as a result of gut microbiota in this study (Fig. S1a). Moreover, the box-plot patterns were very similar between weight gain and adipocyte mean sizes (Fig. 1b and Fig. S1b), which was concordant with representative tissue-staining images, presenting four kinds of adipocyte sizes and hepatic steatosis gradually increased from LFD to HFD (Fig. 1d).

Figure 1

Dietary intervention affects adipocyte size as well as body weight in mice.

Dietary groups were represented as different colors (Red: a high fat diet (HFD), Green: a HFD with 500 mg/kg BW of a probiotics mixture (HFD + P), Blue: a HFD with P + 1,000 mg/kg BW of Garcinia cambogia (HFD + P + G), and Purple: a low fat diet (LFD)) in all plots. Male C57BL/6J mice were fed one of four diets for 9 weeks (n = 7). (a) Body weight curves; Pairwise t-test was employed for significance test from HFD-fed animals (*P < 0.05, **P < 0.01, ***P < 0.001). (b) Different adipocyte mean sizes of four fat tissues such as epididymal adipocyte tissue (EAT), mesenteric adipocyte tissue (MAT), perirenal adipocyte tissue (PAT) and subcutaneous adipocyte tissue (SAT) responding to diet. (c) Density plots of adipocyte size in fat tissues. Y and X-axis are frequency and adipocyte size, respectively. (d) Representative adipose and liver tissue-staining images of four fat pads in mice. From top to bottom, PAT, EAT, SAT, MAT, and hepatic steatosis (HS), respectively. Black-bar is a barometer, which represents 100 microns. A pattern of gradually decreasing adipocyte size in four adipose tissues as well as fat granules in the liver tissue was observed. Data are represented as the mean ± SEM. Pairwise t-test was employed for significance test from HFD-fed animals (*P < 0.05, **P < 0.01, **P < 0.001).

Change of serum biochemical parameters for protein metabolism in response to diet

The serum biochemical parameters were further analyzed to investigate host metabolism in response to diet. Blood urea nitrogen (BUN) and creatinine levels in the serum of HFD and HFD + P mice were found to be significantly lower than those in LFD and HDP + P + G mice (P < 0.001 and P < 0.01, respectively, Fig. S1c). Spearman correlation coefficients among diet, obesity traits and protein metabolism showed that diet order ascending from HFD to LFD had a negative correlation with obesity traits, particularly EAT adipocyte mean size (Correlation coefficient and P-value are −0.89 and 3.65E-10, respectively), and a positive correlation with serum BUN (0.65 and 1.99E-4) and creatinine (0.76 and 2.74E-06) (Fig. S1d). BUN and creatinine were negatively correlated with obesity traits, particularly with EAT adipocyte mean size (−0.66 [1.35E-04] and −0.65 [1.82E-04], respectively). Through correlation analysis, we observed strong linear relationships among diet, obesity traits and protein metabolism.

Characterizing changes in microbial abundance in response to diet

Differentially abundant microbiota (DAM) analysis of 494 annotated operational taxonomic units (OTUs) at the species level was performed to characterize the changes of microbial species in response to diet (Dataset S1). Four types of comparisons were performed: a multi-group test (H1: at least one group ≠ 0 in the four dietary ingredients), HFD vs HFD + P, HFD vs HFD + P + G, and HFD vs LFD (descripted in Supplementary Methods). Of these statistical tests, we focused primarily on the result of the multi-group test given our primary goal of detecting causative bacterial species for obesity-related traits in response to diet. As a result, 266 significant differentially abundant species were identified with false discovery rate (FDR) adjusted P-value < 0.05. The distribution of significantly detected species at the phylum level revealed that most of the annotated phylum was Firmicutes (67%) followed by Bacteroidetes (14.11%) Actinobacteria (10.37%), Proteobacteria (4.15%), and others (<1.66%) (Fig. S2a). The hierarchical clustering analysis of 266 species showed that the faecal samples were clearly separated based on diet (Fig. S2b) except two samples (one HFD + P + G and one HFD + P), confirming that significantly abundant species were strongly influenced by diet. The number of significantly abundant species was highest in LFD (141 species), followed by HFD + P + G (112 species) and HFD + P (48 species) compared with the HFD group (Fig. S2c and Dataset S1). The heatmap of the relative abundances of 50 bacterial species (mostly affiliated with three phyla such as Firmicutes, Bacteroidetes and Actinobacteria) showed that the maximum median proportion (MMP) among dietary groups was more than a thousandth (MMP > 0.1%) and also revealed dietary dependent patterns (Fig. S2a and Dataset S1). The microbial species that are susceptible to diet, showed four representative patterns, which are visualized as box-plots (Fig. S2d). The first is linearly decreasing from HFD to LFD such as C. aminophilum and Oxobacter pfennigii. The second is highly abundant in HFD groups such as Clostridium propionicum, Clostridium scindens and Eubacterium fissicatena. The third is highly abundant in LFD group such as Ruminococcus bromii and rumen bacterium NK4A66. The fourth is highly abundant or suppressed in HFD + P and HFD + P + G groups such as Bifidobacterium breve, Bifidobacterium bifidum, Lactobacillus plantarum, Lactococcus garvieae and Lactobacillus johnsonii. Particularly, C. aminophilum increased 32-fold in HFD mice comparing to LFD mice followed by a 12-fold increase of C. propionicum, which accounted for the highest proportion (MMP = 5.3%) among Clostridium species. Contrastingly, the abundance of R. bromii, a causative starch-degrading bacterium in human colon17, and unclassified rumen bacterium NK4A66 decreased (1.20E-5 and 6.99E-10, respectively). In addition, we observed elevated proportions of bile acid transforming18 (C. scindens) and acetogenic19,20 (O. pfennigii and E. fissicatena) bacteria in HFD mice compared to LFD mice.

Dietary intervention affects the proportion of Bifidobacteria and high fat-induced bacteria

Administration of a probiotic mixture (B. breve, B. bifidum L. plantarum, L. acidophilus and Enterococcus faecium) to HFD mice increased the abundance of 10 species out of the total 16 surveyed Bifidobacteria species including the increases in administrated B. breve and B. bifidum (Fig. 2; See also Dataset S1). However, only 2 out of 34 Lacotobacillus species (L. plantarum and L. pentosus) increased after the probiotic treatment, and the abundance of L. johnsonii, the most abundant commensal species in the genus Lactobacillus (MMP = 0.6%), was reduced due to the external probiotics. In addition, administrated Bifidobacteria decreased proportions of A. butyraticus and L. garvieae, (MMP = 0.3% and 0.1%, respectively). The combination of probiotics and fruit extract decreased the proportion of high fat-induced bacteria such as C. aminophilum and O. pfennigii. Combined dietary intervention (3.42E-8) more effectively suppressed C. aminophilum than a probiotics mixture (0.3) compared to the HFD group; a similar trend was observed for O. pfennigii.

Figure 2

Dietary intervention induces relative abundance alteration in gut microbial species.

The left heatmap illustrates 50 significantly detected species in the multi-group test (FDR adjusted P < 0.05) and maximum median proportion more than a thousandth responding to diet. Species abundance is represented as log2-counts per million reads (log-CPM). The second heatmap represents results of two group comparison based on the HFD group. The phylum level taxonomy is given on the right.

Characterizing obesity trait associated microbiota

A linear regression model was employed to identify obesity trait-associated microbiota (TAM), with five obesity traits including weight gain and four types of adipocyte measures (additional description available in Supplementary Methods). As a result, 62 bacterial species were significantly (FDR adjusted P < 0.1) associated with five obesity traits (Fig. S3a and Table S4). Among those, 51 species were found to overlap between DAM and TAM analyses (Fig. S3b), indicating these commonly identified species not only respond to diet but are also associated with obesity traits. 41 out of 51 bacterial species were highly correlated with EAT adipocyte mean size (Fig. S3a). To identify the relationship between EAT adipocyte mean size and bacterial abundance, the top 15 significantly associated bacterial species were visualized as a fitted line plot. Bacterial species detected by TAM analysis show strong linear relationship (0.36 ≤ R2 ≤ 0.75) (Fig. S3c). Furthermore, the hierarchical clustering analysis of the 48 commonly identified species (excluding two unknown and one plant annotations) displayed two separate groups (Fig. 3), with the lower group having higher species proportions. When the bacterial species were annotated to their corresponding phyla, they were mostly Firmicutes, while only 8 species belonged to Bacteroidetes, Proteobacteria, Streptophyta and Acidobacteria. C. aminophilum was the only species associated with all surveyed obesity traits and the most significantly associated species (FDR adjusted P value = 9.19E-05 in EAT adipocyte mean size). The abundance of C. aminophilum also had a negative association with host parameters of protein metabolism such as serum BUN and creatinine (Fig. S3d). In addition, C. propionicum, a propionic acid producing AP bacterium (28), was positively associated with three obesity traits, and negatively correlated with serum BUN and creatinine.

Figure 3

Obesity traits are highly associated with gut microbial species.

The left heatmap illustrates 48 overlapped species, which are significantly detected in DAM and TAM analyses. Species abundance is represented as log-CPM values. The second heatmap represents test results in TAM analysis with five response variables (FDR adjusted P-value < 0.1).

Correlation based network analysis using relative abundances of significantly detected microbiomes in DAM and TAM with obesity-related traits

Correlation based network analysis was performed using multi-level taxa to visually investigate the microbe-microbe relationships in addition to the afore-mentioned diet-microbe and host-microbe relationships (Fig. 4). As a result, network plots exhibit a highly complex structure despite the strict P-value cut-off for significant relationships (Spearman correlation test with FDR adjusted P < 0.01) at each taxa level. Of the many relationships, two representative sub-networks were observed at the genus and species levels. The first sub-network included diet, obesity traits, and most of the commonly identified bacterial species between DAM and TAM analyses (Fig. 4, Layer 3) with nodes of commonly identified species highly correlated with each other. Particularly, C. aminophilum was highly correlated with commonly identified species (0.334 ≤ R2 ≤ 0.824) and the average Spearman correlation was 0.594 (Table S4), indicating that C. aminophilum is a strong candidate for diet driven obesity. In the second sub-network, administrated probiotics (B. breve, B. bifidum L. plantarum and L. acidophilus) formed complex nodes with surrounding commensal Bifiodobacteiria, Lactobacilli, L. garvieae and E. durans, indicating an important role of external probiotics to overall bacterial abundance.

Figure 4

Correlation based network using relative abundance of gut microbes on multi-level taxa.

Each node represents each phylotype in the different taxonomic layers (plylum, genus, and species). The green and red edge represents the direction of Spearman correlation; positive and negative, respectively. In addition, line width indicates the strength of correlation. Only the significant edges are drawn in the network using the Spearman correlation test (FDR adjusted P < 0.01). In Layer 1, relationships between the relative abundance of phyla and traits including diet are represented with full labelling. Second and third layers represent the relationships in genus and species level, respectively. In Layer 3, 48 significantly detected species from the DAM and TAM analyses (black texts), and administrated probiotics such as B. breve, B. bifidum, L. plantarum, and L. acidophilus with other surrounding commensal bacteria (blue texts) are labeled.


In this study, we selected probiotics and Garcinia cambogia extract for dietary intervention, which have been reported to support weight management in humans. Some probiotic strains and probiotic mixtures were shown to be effective in weight loss, visceral adiposity, and related metabolic syndrome in animals13,14,21. Garcinia cambogia extract containing hydroxycitric acid (HCA), known as an inhibitor of ATP-citrate-lyase in fatty acid biosynthesis, attenuated obesity traits in humans and animals22,23. However, these interventions are controversial in their efficacy in humans24,25. We presume that probiotic strains used in this study would be integrated into gut microbiota, promoting its composition to the direction of attenuation in obesity development, in synergy with host metabolism influenced by Garcinia cambogia extract.

The combination of these two supplements reduced weight gain and adipocyte mean sizes, but the use of probiotics alone attenuated adipocyte mean sizes only. Statistically, adipocyte mean size is generally preferred over weight gain because of its robustness and sentiveness26. In addition, we presumed that associated microbes may be associated more with metabolically active EAT (equivalent to human VAT) than SAT27. Concordantly, our TAM results support that epididymal adipocyte mean size is more sensitive than other measurements for the degree of obesity (Weight gain, PAT, SAT, and MAT), as shown in Fig. S3. However, further research is required to clearly understand the degree of association between microbes and different adipose depots.

The main objective of this study is to determine effectively whether combined supplements substantially modulate obesity-associated microbes characterized in mice with diet-induced obesity. To achieve this objective, two types of statistical tests were jointly employed to identify obesity-causative microbes (Fig. S4; see also supplementary methods). Recently, metagenome analysis has focused solely on the detection of DAM in given experimental conditions. However, only comparing the relative abundance is a limited approach in that diet-induced gut microbes may not be obesity-associated microbes. Instead, they can be consequences of microbial fermentation responding to their preferred dietary ingredients. Given the situation, we presumed that diet-driven causative microbial candidates should be DAM responding to diet as well as significantly associated with obesity phenotypes and various recent attempts on obesity-associated microbes detection using linear regression models have been successfully reported28,29,30. For these reasons, a two-stage statistical test on DAM and TAM was simultaneously considered, which was suitable for this study. Considering our objective of detecting causative microbes, of changing obesity traits responding to dietary intervention, the candidate microbes should not only be differentially abundant in response to diet, but also significantly associated with obesity-related traits. As far as we know, although this approach has been previously used in transcriptomic studies, this is the first attempt to use it in the microbiome study31. The progression of method development in this field is similar to that of transcriptome analysis such as RNA-seq and microarray. Therefore, a well-developed statistical methodology for identifying causal genes could be applied to the microbial community analysis with minor adjustments32. Especially, application of network analysis is important in gut microbiota research because a microbial community is composed of complex relationships comparable to the transcriptome. While several metagenome studies have been performed with network analysis and pivotal OTUs in the microbe-microbe relationships have been successfully detected, complex causality relationships (diet-microbe, host-microbe, and microbe-microbe) were utilized in this study for the first time (Fig. 4).

A greater number of gut microbes were affected by LFD (141 species), HFD + P + G (112 species) and HFD + P (48 species), in order, compared to the HFD feeding. HFD feeding increased the abundance of many species affiliated with the phylum Firmicutes (Fig. 2), which is in agreement with other studies5,9,14. Pathophysiological evidence supports our finding that HFD-driven microbiota increases gut permeability and metabolic endotoxemia resulting in chronic inflammation on adipocytes; as a result, exacerbates obesity and its metabolic syndrome33,34,35. However, while probiotics promoted the abundance of other commensal Bifidobacteria, the probiotic effect on abundance was minimal to commensal Lactobacilli.

We observed that the combination of probiotics and Garcinia cambogia extract highly changed the gut microbial community compared to the effect of probiotics only. Because many researchers have focused on the role of HCA for the control of host adiposity in the point of fatty acid metabolism, not much is known about the effect of Garcinia cambogia extract on gut microbiota and its modulating potential. Taking into account that Garcinia cambogia extract is polyphenol-rich, performs antibacterial and antioxidant functions36, and ameliorates gastric ulcer37 and colitis in rats38, we hypothesized that it could modulate gut microbiota in the mode of action of polyphenols proposed by other in vitro and in vivo studies15,16,39,40. Our DAM results may explain, in part, the controversy on the efficacy of Garcinia cambogia extract on weight loss and adiposity in humans23,24,41, affected by the compositional variation of individual gut microbiota42. Our study selected probiotics and Garcinia cambogia extract, for dietary intervention showed increased abundance of Bifidobacteria and decreased hyper-ammonia-producing (HAP) bacteria, suggesting the potential to reduce obesity through manipulation of gut microbiota under high-fat diet. This is the first study to reveal that dietary interventions such as additional probiotics or polyphenol-rich fruit extract are plausible candidates to suppress the blooming of HAP and analogs in the gut microbial community in humans.

In this study, a HFD + G and P + G groups were not considered,therefore the individual effect of Garcinia cambogia extract cannot be characterized. Further studies are needed to determine whether the sole use of Garcinia cambogia extract effectively changes gut microbial community and how much it contributes to alleviating obesity development via microbial modulation comparing to the known role of down-regulating fatty acid synthesis in the host.

As a result of a two-stage statistical test on 16S rRNA taxonomic data, 48 bacterial species were identified as putative candidates for host-microbe interaction in the development of obesity. Of note, C. aminophilum, the member of HAP bacteria and non-saccharolytic obligate amino acid fermenters, was highly abundant, and the most significantly associated with weight gain and adipocyte sizes in mice, which was suppressed by the combined use of probiotics and Garcinia cambogia extract in HFD mice. The typical HFD mimicking a Western-style diet (Table S1) in our study contains only 20% of energy from carbohydrates such as sucrose (7%) and maltodextrin (12%) quickly absorbed by upper small intestine43,44, which may induce the depletion of carbohydrates in distal ileum and colon where the majority number of gut microbes reside45. We speculate that such severe depletion shifted the dominant bacteria from carbohydrate to amino acid fermenters such as C. aminophilum and C. propionicum in HFD mice. The changes in microbial transcriptome and metabolites on amino acid and carbohydrate metabolism in Western-style diet reported by other gut microbiome studies8,12 are in agreement with the blooming of amino acid fermenters and the withering of R. bromii in HFD mice. In cattle and dairy cows, ammonia-producing (AP) bacteria have been intensively investigated to better understand excess ammonia production and amino acid wasting for meat and milk production46. Since the late 1980s, researchers have reported that specific AP bacterial species with very high ammonia producing activity (>300 nmol NH3 mg−1 protein min−1) mostly affiliated with the genus Clostridium, Eubacterium, Peptostreptococcus in the phylum Firmicutes47,48,49,50,51. These HAP bacteria play a causative role in influencing microbial nitrogen metabolism by producing NH3 up to 20-fold faster than other AP bacteria48,50,51,52. Interestingly, the abundance of C. aminophilum and C. propionicum had a negative association with serum blood urea nitrogen and creatinine (Fig. S3d). Further research is required to elucidate why these bacteria are associated with host protein metabolites and whether they are involved in the development of obesity.

The two-stage test also revealed increased abundance of a bile acid transformer and other bacterial groups which responded to diet and were associated with obesity traits. The abundance of C. scindens, which is responsible for converting primary bile acids to secondary deteriorated bile acids18, was increased 7-fold after HFD (Fig. S2). The abundance of acetogens such as O. pfennigii and Acetobacterium woodii in the class Clostridia were positively associated with obesity traits (Fig. S3c), suggesting their role may be related to efficiency for energy harvest in the large bowel53. O. pfennigi, previously classified as Clostridium pfennigi, produces acetate and butyrate using CO19, and A. woodii, homoacetogens, produces acetate only using H2 gas and CO2, eliminating accumulated H2 gas for gut microbiota to consistently ferment substrates54. Candidatus Arthromitus sp. SFB-mouse, nonpathogenic segmented filamentous bacteria related with induction of strong host immune responses to intestinal epithelial cell55, showed a positive linear relationship with EAT adipocyte mean size (Fig. S3c). Further research using molecular and pathophysiological approaches is needed to validate our results based on correlative analyses.

In conclusion, various attempts to understand the dynamic relationship between gut microbiota and obesity-related traits responding to diet revealed which gut microbes are associated with obesity phenotypes. First, obesity-related 48 species candidates were identified from DAM and TAM analyses. Also, the result of network analysis provides the blueprint to explain the complex relationship among microbes, diet, and host’ phenotypes, which possibly explains the effect of probiotics and Garcinia cambogia extract on gut microbiota features associated with obesity traits. Employed methodology and following results could be applied to further research the taxonomic signature of obesity to develop dietary intervention and treatments supporting weight management in overweight and obese humans.

Materials and Methods

Animals and diets

Male C57BL/6J mice (6 weeks old, n = 7 per group) were purchased from Orient Bio Inc. (Sungnam, South Korea). Mice were housed in autoclaved cages (three or four mice per cage) in a pathogen-free room with the temperature and relative humidity at 22 ± 2 °C and 50 ± 10%, respectively, under a 12-h light-dark cycle. The low fat (LFD; fat 10 kcal%, carbohydrate 70 kcal%, protein 20kcal%; D12450B) and high fat (HFD; fat 60 kcal%, carbohydrate 20 kcal%, protein 20 kcal%; D12492) diets were obtained from Research Diets Inc., New Brunswick, NJ (Table S1). All animal studies were performed in accordance with the Korean Food and Drug Administration (KFDA) guidelines. The experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee of the INHA University (No. 140728-320).

The probiotic mixture (1 × 1011 CFU/g) based on Double Impact® formula (DI formula) and Garcinia cambogia extract (HCA content is over 60%) originated from the INDFRAG (India); Product name is garcinia cambogia husk extract PE65, was obtained from CTC Bio Co., Ltd., Seoul, Korea. The probiotic mixture consisted of two strains of Bifidobacteria (B. breve LMC520 (2 × 1010 CFU/g; 20%) and B. bifidum CBF0829 (2 × 1010 CFU/g; 20%)), two strains of Lactobacilli (L. acidophilus CLB0413 (0.8 × 1010 CFU/g; 8%) and L. plantarum CLP0611 (2.4 × 1010 CFU/g; 24%)) and one strain of Enterococcus faecium CEF-1 (2.8 × 1010 CFU/g; 28%). After a 1 week acclimatization period on LFD, mice were divided into four weight-matched groups: LFD group, HFD group, HFD + probiotics mixture (500 mg/kg body weight) (HFD + P) group, HFD + probiotics mixture (500 mg/kg body weight) and Garcinia cambogia extract (1,000 mg/kg body weight) (HFD + P + G) group. Probiotics and Garcinia cambogia extract (dissolved in PBS) were administrated by oral gavage, and LFD and HFD groups were treated with equal volumes of PBS for 9 weeks. Irradiated diets and water were fed ad libitum, and body weight and feed intake was recorded twice every week. At the end of the animal study, all the mice fasted overnight and were anesthetized with Zoletil® and Rompun®. Blood was collected by cardiac puncture, and serum was isolated by centrifugation at 3,000 rpm for 10 min at 4 °C, and stored at −80 °C for further biochemical analyses. Mice were sacrificed by cervical dislocation after blood collection. Adipose tissues (perirenal, epididymal, subcutaneous, mesenteric) and liver were removed precisely, and then weighed.

Histochemical staining and adipocyte surface area analysis

Adipose tissues (mesenteric, subcutaneous, epididymal, and perirenal) and liver tissues were fixed with 10% buffered neutral formalin, embedded in paraffin, sectioned at 4 μm, stained with hematoxylin and eosin, viewed with Axioplan 2 imaging (CarlZeiss, Jena, Germany), and photographed at a final magnification of 400X. Adipocyte sizes were measured using Molecular Imaging software (Bruker Biospin, Woodbridge, CT, USA).

Statistical analysis for mice experiment

Data is represented as the mean ± SEM. Adipocyte mean areas and body weight gain were analyzed using a pairwise t-test. Body weight gain curves were statistically compared by using a two-way repeated measures ANOVA. All statistical results were significantly considered at P-value < 0.05. Statistical analysis was performed by using R.

Fecal DNA preparation and microbial community analysis

Fecal pellets were collected from individual mice in a sterile tube and immediately frozen by dry ice and stored at −80 °C. DNA was isolated using Epicentre DNA isolation kits (7 biological replicates in each dietary group). Approximately 900 ng of DNA was extracted from each sample. DNA quality was confirmed by Bioanalyzer using an Agilent RNA 6000 Pico Kit (Agilent, Santa Clara, CA). All samples from the reservoir were prepared using the 16S library preparation protocol and the Nextera XT DNA index kit (illumina, San Diego, CA) to target the V3-V4 variable regions of the 16S rRNA gene. Library quantification was measured by real-time PCR using the CFX96 real time system (BioRad, Hercules, CA). 22 from a total of 28 mice samples passed the experimental quality control, and six samples (2 LFD, 1 HFD, and 3 HFD + P samples) failed to generate amplicon because of the subject’s poor fecal state (diarrhea). Samples from the reservoir were loaded onto a MiSeq reagent catridge (illumina, San Diego, CA) and then onto the instrument. Automated cluster generation and 2 × 300 bp paired-end sequencing were performed. The resulting sequence reads were equally distributed across the samples.

Pipeline for microbial community analysis

We employed Trimmomatic56 with the following options: PE -phred33 ILLUMINACLIP:TruSeq3-PE.fa:2:30:10 MINLEN:75 2 for removing adapter sequences on each read. After generating clean reads, we overlapped sequences using FLASH-1.2.1157 with the following options: –min-overlap 30 –max-overlap 200. These pre-processed sequences were uploaded to the MG-RAST server58 for calculation of microbioal features. Microbial features were extracted using the MG-RAST analysis tool.

Statistical analysis for microbial community analysis

Multi-level taxonomic abundance was extracted using MG-RAST. A negative bionomical based generalized linear model (GLM) was used to detect differentially abundant microbiota (DAM). For consideration of different read production, the trimmed mean of M-values (TMM) normalization method was used. Finally, a simple linear regression model was used for detecting trait associated microbiota (TAM). All statistical test results were adjusted using the Benjamini-Hochberg method59 for correction of multiple testing errors, setting the FDR at 10%. A more detailed description of statistical methods is available in Supplementary Methods.

Additional Information

Accession codes: The microbial sequencing data has been deposited in NCBI’s BioProject (PRJNA290695) and SRA sequence database (SRR2124868).

How to cite this article: Heo, J. et al. Gut microbiota Modulated by Probiotics and Garcinia cambogia Extract Correlate with Weight Gain and Adipocyte Sizes in High Fat-Fed Mice. Sci. Rep. 6, 33566; doi: 10.1038/srep33566 (2016).


  1. Eyre, H. et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association*†. CA: a cancer journal for clinicians 54, 190–207 (2004).

    Google Scholar 

  2. Serino, M. et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61, 543–553 (2012).

    CAS  Article  PubMed  Google Scholar 

  3. Ridaura, V. K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, doi: 10.1126/science.1241214 (2013).

  4. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).

    CAS  ADS  Article  Google Scholar 

  5. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1131 (2006).

    ADS  Article  Google Scholar 

  6. Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences 110, 9066–9071 (2013).

    CAS  Article  ADS  Google Scholar 

  7. Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705–721 (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).

    CAS  Article  ADS  Google Scholar 

  9. Woting, A., Pfeiffer, N., Loh, G., Klaus, S. & Blaut, M. Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. MBio 5, doi: 10.1128/mBio.01530-14 (2014).

  10. Graham, C., Mullen, A. & Whelan, K. Obesity and the gastrointestinal microbiota: a review of associations and mechanisms. Nutrition Reviews, doi: 10.1093/nutrit/nuv004 (2015).

  11. Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480–484 (2009).

    CAS  Article  ADS  Google Scholar 

  12. Daniel, H. et al. High-fat diet alters gut microbiota physiology in mice. The ISME journal 8, 295–308 (2014).

    CAS  Article  PubMed  Google Scholar 

  13. Yadav, H., Lee, J.-H., Lloyd, J., Walter, P. & Rane, S. G. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry 288, 25088–25097 (2013).

    CAS  Article  PubMed  Google Scholar 

  14. Wang, J. et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. The ISME journal 9, 1–15 (2015).

    Article  CAS  Google Scholar 

  15. Anhê, F. F. et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut, doi: 10.1136/gutjnl-2014-307142 (2014).

  16. Roopchand, D. E. et al. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high fat diet-induced metabolic syndrome. Diabetes, doi: 10.2337/db14-1916 (2015).

  17. Ze, X., Duncan, S. H., Louis, P. & Flint, H. J. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. The ISME journal 6, 1535–1543 (2012).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. Ridlon, J. M., Kang, D.-J. & Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. Journal of lipid research 47, 241–259 (2006).

    CAS  Article  PubMed  Google Scholar 

  19. Krumholz, L. & Bryant, M. Clostridium pfennigii sp. nov. uses methoxyl groups of monobenzenoids and produces butyrate. International journal of systematic bacteriology 35, 454–456 (1985).

    CAS  Article  Google Scholar 

  20. TAYLOR, M. M. Eubacterium fissicatena sp. nov. isolated from the alimentary tract of the goat. Journal of general microbiology 71, 457–463 (1972).

    CAS  Article  PubMed  Google Scholar 

  21. Mekkes, M., Weenen, T., Brummer, R. & Claassen, E. The development of probiotic treatment in obesity: a review. Beneficial microbes 5, 19–28 (2014).

    CAS  Article  PubMed  Google Scholar 

  22. Asghar, M. et al. Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats. Molecular and cellular biochemistry 304, 93–99 (2007).

    CAS  Article  PubMed  Google Scholar 

  23. Preuss, H. et al. An overview of the safety and efficacy of a novel, natural (−)-hydroxycitric acid extract (HCA-SX) for weight management. Journal of medicine 35, 33–48 (2003).

    Google Scholar 

  24. Márquez, F., Babio, N., Bulló, M. & Salas-Salvadó, J. Evaluation of the safety and efficacy of hydroxycitric acid or Garcinia cambogia extracts in humans. Critical reviews in food science and nutrition 52, 585–594 (2012).

    Article  PubMed  Google Scholar 

  25. Delzenne, N. M., Neyrinck, A. M., Bäckhed, F. & Cani, P. D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature Reviews Endocrinology 7, 639–646 (2011).

    CAS  Article  PubMed  Google Scholar 

  26. Chen, H. C. & Farese, R. V. Determination of adipocyte size by computer image analysis. Journal of lipid research 43, 986–989 (2002).

    CAS  PubMed  Google Scholar 

  27. Bjørndal, B., Burri, L., Staalesen, V., Skorve, J. & Berge, R. K. Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. Journal of obesity, doi: 10.1155/2011/490650(2011) (2011).

  28. Korpela, K. et al. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PloS one 9, doi: 10.1371/journal.pone.0090702 (2014).

  29. Parks, B. W. et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell metabolism 17, 141–152 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. Cox, L. M. et al. The nonfermentable dietary fiber hydroxypropyl methylcellulose modulates intestinal microbiota. The FASEB Journal 27, 692–702 (2013).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  31. Bae, Y. J. et al. Selection of differentially expressed gene in the colon of the mice fed high-fat diet associated with blood adipokine concentrations as early biomarkers of pathological changes. The FASEB Journal 27, doi: 10.1096/fj.1530-6860 (2013).

  32. McMurdie, P. J. & Holmes, S. Waste not, want not: why rarefying microbiome data is inadmissible. PLoS Computational Biology 10, doi: 10.1371/journal.pcbi.1003531 (2014).

  33. Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes 57, 1470–1481 (2008).

    CAS  Article  PubMed  Google Scholar 

  34. Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology 9, 313–323 (2009).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. Geurts, L. et al. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Frontiers in microbiology 2, doi: 10.3389/fmicb.2011.00149 (2011).

  36. Shivakumar, S., Sandhiya, S., Subhasree, N., Agrawal, A. & Dubey, G. In vitro assessment of antibacterial and antioxidant activities of fruit rind extracts of Garcinia cambogiaL. Int J Pharm Pharm Sci 5, 254–257 (2013).

    Google Scholar 

  37. Mahendran, P., Vanisree, A. & Devi, S. The antiulcer activity of Garcinia cambogia extract against indomethacin‐induced gastric ulcer in rats. Phytotherapy research 16, 80–83 (2002).

    CAS  Article  PubMed  Google Scholar 

  38. dos Reis, S. B. et al. Attenuation of colitis injury in rats using Garcinia cambogia extract. Phytotherapy research 23, 324–329 (2009).

    Article  CAS  PubMed  Google Scholar 

  39. Duda-Chodak, A. The inhibitory effect of polyphenols on human gut microbiota. J. Physiol. Pharmacol 63, 497–503 (2012).

    CAS  PubMed  Google Scholar 

  40. Etxeberria, U. et al. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. Journal of agricultural and food chemistry 61, 9517–9533 (2013).

    CAS  Article  PubMed  Google Scholar 

  41. Heymsfield, S. B. et al. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. Jama 280, 1596–1600 (1998).

    CAS  Article  PubMed  Google Scholar 

  42. Salonen, A. et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. The ISME journal 8, 2218–2230 (2014).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. Riesenfeld, G., Sklan, D., Bar, A., Eisner, U. & Hurwitz, S. Glucose absorption and starch digestion in the intestine of the chicken. J. Nutr 110, 117–121 (1980).

    CAS  Article  PubMed  Google Scholar 

  44. Borgström, B., Dahlqvist, A., Lundh, G. & Sjövall, J. Studies of intestinal digestion and absorption in the human. Journal of Clinical Investigation 36, 1521 (1957).

    Article  PubMed  PubMed Central  Google Scholar 

  45. Sartor, R. B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577–594 (2008).

    CAS  Article  PubMed  Google Scholar 

  46. Russell, J. B. & Strobel, H. Effect of ionophores on ruminal fermentation. Applied and environmental microbiology 55, 1 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Russell, J., Strobel, H. & Chen, G. Enrichment and isolation of a ruminal bacterium with a very high specific activity of ammonia production. Applied and environmental microbiology 54, 872–877 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Chen, G. & Russell, J. More monensin-sensitive, ammonia-producing bacteria from the rumen. Applied and environmental microbiology 55, 1052–1057 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Attwood, G. T., Klieve, A. V., Ouwerkerk, D. & Patel, B. K. Ammonia-hyperproducing bacteria from New Zealand ruminants. Applied and environmental microbiology 64, 1796–1804 (1998).

    CAS  PubMed  PubMed Central  Google Scholar 

  50. McSweeney, C. S., Palmer, B., Bunch, R. & Krause, D. O. Isolation and characterization of proteolytic ruminal bacteria from sheep and goats fed the tannin-containing shrub legume Calliandra calothyrsus. Applied and environmental microbiology 65, 3075–3083 (1999).

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Eschenlauer, S. et al. Ammonia production by ruminal microorganisms and enumeration, isolation, and characterization of bacteria capable of growth on peptides and amino acids from the sheep rumen. Applied and environmental microbiology 68, 4925–4931 (2002).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  52. Yang, C. & Russell, J. Effect of monensin on the specific activity of ammonia production by ruminal bacteria and disappearance of amino nitrogen from the rumen. Applied and environmental microbiology 59, 3250–3254 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  53. BALCH, W. E., Schoberth, S., TANNER, R. S. & Wolfe, R. Acetobacterium, a new genus of hydrogen-oxidizing, carbon dioxide-reducing, anaerobic bacteria. International journal of systematic bacteriology 27, 355–361 (1977).

    CAS  Article  Google Scholar 

  54. Menger, William, M. et al. “Microbial process for producing methane from coal.” United States patent US 6(143), 534 (2000).

  55. Klaasen, H. et al. Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infection and immunity 61, 303–306 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  56. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics, doi: 10.1093/bioinformatics/btu170 (2014).

  57. Magoč, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957–2963 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Glass, E. M., Wilkening, J., Wilke, A., Antonopoulos, D. & Meyer, F. Using the metagenomics RAST server (MG-RAST) for analyzing shotgun metagenomes. Cold Spring Harbor Protocols 1, doi: 10.1101/pdb.prot5368 (2010).

  59. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological), 289–300 (1995).

Download references


This work was supported by the innovative scientific research grant from CTCBIO.

Author information




J.H., M.S., J.Y. and K.C.-A. wrote the manuscript. J.H., W.K.L., Y.-M.K., S.-Y.K., S.C. and H.K. designed the research. H.P. and W.K.L. performed the mice experiments. M.S., J.H. and H.A. analyzed data on the mice experimental data. M.S. performed microbial community analysis. L.L.G., J.Y. and K.C.-A. critically revised the manuscript. H.K. and S.C. supervised the research.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Electronic supplementary material

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Heo, J., Seo, M., Park, H. et al. Gut microbiota Modulated by Probiotics and Garcinia cambogia Extract Correlate with Weight Gain and Adipocyte Sizes in High Fat-Fed Mice. Sci Rep 6, 33566 (2016).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing